Tauroursodeoxycholic acid (TUDCA) ameliorates age‐related skeletal muscle loss
The Journal of Physiology · 2026-06 · 604 (12) · 4795-4814
DOI: 10.1113/jp290683 ↗At a glance
Journal article in The Journal of Physiology, published online on 2026-05-15. Written by Marina S Carvalho and 7 co-authors. Institution: Obesity and Comorbidities Research Center, Department of Structural and Functional Biology, University of Campinas, UNICAMP, Campinas, Sao Paulo, Bra…. Major MEDLINE topics: Taurochenodeoxycholic Acid, Muscle, Skeletal, Aging. Cited 2 times so far (Crossref); 104 references. Funded by: Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (original language)
Ageing leads to changes in body composition, including increased adiposity and reduced skeletal muscle mass and force. The alterations in ageing skeletal muscle result from impaired proteostasis driven by factors such as chronic inflammation, hormonal changes and reduced nutrient absorption. Those age‐related changes in body composition and skeletal muscle compromise mobility and increase the risk of falls, fractures and metabolic disorders. Tauroursodeoxycholic acid (TUDCA), a bile acid with known benefits in chronic diseases, has been shown by our group to improve cognition and metabolic homeostasis in ageing and Alzheimer's disease mouse models. Interestingly, in previous studies, TUDCA treatment was also associated with increased skeletal muscle mass in ageing mice, leading us to hypothesize that TUDCA could target skeletal muscle to reduce age‐related muscle loss. To explore this, we treated 18‐month‐old C57BL/6 mice with TUDCA or vehicle for 20 days, using 3‐month‐old mice as a young control group. We demonstrate that TUDCA treatment decreases body weight while increasing skeletal muscle mass, restores muscle fibre size and preserves functional integrity. Additionally, TUDCA enhances skeletal muscle insulin sensitivity through increased AKT activation and reduces tissue inflammation. Such improvements collectively support the restoration of skeletal muscle proteostasis, as indicated by increased protein synthesis and phosphorylation of key anabolic signalling pathways, including ribosomal protein S6 kinase beta‐1 (P70S6K) and eukaryotic translation initiation factor 4E‐binding protein 1 (4EBP1). These findings contribute to a better understanding of TUDCA's actions on skeletal muscles of ageing mice and highlight its role as a promising strategy against age‐related muscle loss. image Key points Tauroursodeoxycholic acid (TUDCA) treatment attenuates skeletal muscle loss in ageing mice. TUDCA improves skeletal muscle insulin sensitivity and restores AKT signalling. TUDCA exerts an anti‐inflammatory effect in skeletal muscle of ageing mice. TUDCA emerges as a potential therapy for age‐related skeletal muscle loss.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Obesity and Comorbidities Research Center, Department of Structural and Functional Biology, University of Campinas, UNICAMP, Campinas, Sao Paulo, Brazil.
- Laboratory of Vascular Biology, Department of Structural and Functional Biology, University of Campinas, UNICAMP, Campinas, Sao Paulo, Brazil.
- Laboratory of Nutrition and Cancer, Department of Structural and Functional Biology, University of Campinas, Campinas, Sao Paulo, Brazil.
- Department of Pharmacology and Physiology, Université de Montréal, Faculty of Medicine, Montreal, Quebec, Canada.
ORCID profiles: Marina S Carvalho, Lohanna M B Dos Santos, Maria Cristina C Gomes-Marcondes, Helena C L Barbosa, Lucas Zangerolamo
Funding
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Cite
APA
Carvalho, M. S., Barssotti, L., Santos, L. M. B. D., Rosa, L. R. O., Gomes-Marcondes, M. C. C., Carneiro, E. M., Barbosa, H. C. L., & Zangerolamo, L. (2026). Tauroursodeoxycholic acid (TUDCA) ameliorates age‐related skeletal muscle loss. The Journal of Physiology, 604(12), 4795-4814. https://doi.org/10.1113/jp290683
Vancouver
Carvalho MS, Barssotti L, Santos LMBD, Rosa LRO, Gomes-Marcondes MCC, Carneiro EM, et al. Tauroursodeoxycholic acid (TUDCA) ameliorates age‐related skeletal muscle loss. The Journal of Physiology. 2026;604(12):4795-4814. doi:10.1113/jp290683
BibTeX
@article{Carvalho2026,
author = {Carvalho, Marina S and Barssotti, Leticia and Santos, Lohanna M B Dos and Rosa, Lucas R O and Gomes-Marcondes, Maria Cristina C and Carneiro, Everardo M and Barbosa, Helena C L and Zangerolamo, Lucas},
title = {Tauroursodeoxycholic acid (TUDCA) ameliorates age‐related skeletal muscle loss},
journal = {The Journal of Physiology},
year = {2026},
volume = {604},
number = {12},
pages = {4795--4814},
doi = {10.1113/jp290683}
}
EUVIMED